NVDA
NVIDIA Corporation
NVDA has the edge over XPER overall, supported by stronger valuation and stronger modeled upside.
XPER
Xperi Inc.
XPER's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
XPER Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Healthy |
XPER's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
XPER PE Valuation
XPER has no meaningful PE right now: it lost money over the past year.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
XPER Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
XPER has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over XPER on earnings quality, reporting a profit while its opponent remains loss making.
XPER Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.07 | — |
| Q3 2026 | -$0.68 | -525% |
| Q2 2026 | -$0.70 | -$0.62 |
| Q1 2026 | -$0.99 | -$0.56 |
| Q4 2025 | -$1.23 | -$0.92 |
| Q3 2025 | $0.16 | +$2.05 |
| Q2 2025 | -$0.08 | +$2.40 |
| Q1 2025 | -$0.43 | +$2.28 |
| Q4 2024 | -$0.31 | +$2.87 |
XPER has swung to a loss: it lost $0.68 per share over the past year, after a profit the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over XPER on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over XPER on profitability, with a higher operating margin.
XPER Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $114M | +2.1% |
| Q2 2026 | $114.5M | +8.1% |
| Q1 2026 | $114.2M | +0.2% |
| Q4 2025 | $116.5M | -4.8% |
| Q3 2025 | $111.6M | -16% |
| Q2 2025 | $105.9M | -11% |
| Q1 2025 | $114M | -4% |
| Q4 2024 | $122.4M | -11% |
XPER's revenue fell from its 2020 peak and has held roughly level since: $114M last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.6% | +2.8 points |
| Q2 2026 | 2.5% | +13 points |
| Q1 2026 | 1.9% | +16 points |
| Q4 2025 | -13% | -1 points |
| Q3 2025 | -1.2% | +13 points |
| Q2 2025 | -11% | +7.8 points |
| Q1 2025 | -14% | +13 points |
| Q4 2024 | -12% | +10 points |
XPER's operating margin was 1.6% last quarter, up 2.8 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over XPER on cash generation, producing positive trailing cash flow while its opponent burns cash.
XPER Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.3M | -51% |
| Q2 2026 | $14.1M | +47% |
| Q1 2026 | -$19.1M | +$4.2M |
| Q4 2025 | $1.2M | +$1.7M |
| Q3 2025 | $6.7M | +$12.4M |
| Q2 2025 | $9.5M | +$12.1M |
| Q1 2025 | -$23.3M | +$28.3M |
| Q4 2024 | -$510K | -103% |
XPER's free cash flow was −$633,000 over the past year, against −$8M the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over XPER on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
XPER Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +360K shares |
| 1 year | +5.4% | +2.5M shares |
| 3 years | +13% | +5.5M shares |
| 5 years | +17% | +7.1M shares |
| Available history | -2.8% | -1.4M shares |
XPER has 49M diluted shares, up 5.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q4 2024 | $10M |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | $31.9M |
| Q2 2021 | $11M |
| Q1 2021 | $32.4M |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
XPER Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -12.5x | Net Cash |
| Q3 2025 | -8.5x | Net Cash |
| Q3 2021 | 2.9x | Moderate |
| Q2 2021 | 2.5x | Moderate |
| Q1 2021 | 2.6x | Moderate |
XPER has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
XPER Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.8 | Neutral |
| Stochastic | 30.8 | Neutral |
XPER's weekly RSI is 50 (neutral) and its Stochastic is 31 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
XPER PE vs Technology Sector
| Metric | XPER | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
XPER has no meaningful PE right now: it lost money over the past year.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
XPER Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.44 | 13% above |
| 20 week MA | $6.27 | 1.9% below |
| 50 week MA | $6.37 | 3.5% below |
| 100 week MA | $6.94 | 11% below |
| 200 week MA | $8.51 | 28% below |
XPER has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 28% below its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
XPER Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $14.8 | $8.35 | -44% |
| 2023 | $8.35 | $11.0 | +32% |
| 2024 | $11.0 | $10.1 | -8.1% |
| 2025 | $10.1 | $5.93 | -41% |
| 2026 YTD | $5.93 | $6.15 | +3.7% |
XPER has the edge over NVDA on returns for 2026, with the stronger performance.